On Jan. 26, 2021, Moderna reported that 30.4 million doses have been supplied to the U.S. Government to date. The Company was working closely with the U.S. Government to provide regular updates on supply and production. Approximately 10.1 million doses had been administered in the U.S., according to the U.S. Centers for Disease Control and Prevention.

Short term delays in the final stages of production and release of filled vials at Moderna’s fill and finish contractor Catalent had delayed the release of some doses, but these delays were expected to be resolved in the near term and were not expected to impact monthly delivery targets.